Each vial contains 5mg of TB-500 (Thymosin Beta-4 analogue) and 5mg of BPC-157 (Body Protection Compound-157), co-lyophilised into a single vial for research convenience
Read professional profile Dr Giedre Narkiene Medical doctor and board-certified dermatologist with expertise in medical and cosmetic dermatology, skin health and patient safety
Keep a short log of sleep, stress, and protein intake
Food and Drug Administration has classified BPC-157, GHK-Cu (for injectable routes of administration), and TB-500 (Thymosin 4 fragment) as Category 2 Bulk Drug Substancessubstances with safety concerns that are prohibited from being compounded by licensed pharmacies for human use
Consult your doctor before using the medicine
Some research suggests combining both agents may provide synergistic benefits, though this requires careful formulation (pH, stability considerations)